Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 3, Issue 1
Two case reports of acquired haemophilia A as complications of alemtuzumab treatment for multiple sclerosis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Short report
Two case reports of acquired haemophilia A as complications of alemtuzumab treatment for multiple sclerosis
Online download statistics by month:
Online download statistics by month: January 2021 to December 2022
Abstract
Full
Pdf
Jan 2021
66
66
27
Feb 2021
132
132
15
Mar 2021
162
162
22
Apr 2021
132
132
19
May 2021
171
171
9
Jun 2021
101
101
9
Jul 2021
107
109
13
Aug 2021
113
114
15
Sep 2021
108
108
10
Oct 2021
82
82
28
Nov 2021
121
121
17
Dec 2021
131
132
7
Jan 2022
124
125
5
Feb 2022
86
86
2
Mar 2022
92
92
11
Apr 2022
40
40
2
May 2022
57
57
12
Jun 2022
49
50
10
Jul 2022
43
43
4
Aug 2022
86
86
47
Sep 2022
53
53
16
Oct 2022
55
55
9
Nov 2022
41
41
7
Dec 2022
28
28
5
Total
2180
2186
321
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?